INOTIV INC (NOTV)
US45783Q1004 - Common Stock
NOTV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of NOTV have multiple concerns. NOTV is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
NOTV had a positive operating cash flow in the past year.
In the past 5 years NOTV reported 4 times negative net income.
NOTV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of NOTV (-12.81%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -54.48%, NOTV is doing worse than 70.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.81% | ||
| ROE | -54.48% | ||
| ROIC | N/A |
ROA(3y)-14.63%
ROA(5y)-10.68%
ROE(3y)-40.73%
ROE(5y)-38.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 24.93%, NOTV is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NOTV has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for NOTV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.33%
GM growth 5Y-1.26%
2. Health
2.1 Basic Checks
NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NOTV has more shares outstanding
The number of shares outstanding for NOTV has been increased compared to 5 years ago.
NOTV has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.89, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
NOTV's Altman-Z score of -0.89 is on the low side compared to the rest of the industry. NOTV is outperformed by 72.73% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that NOTV is not too dependend on debt financing.
NOTV has a Debt to Equity ratio of 0.02. This is in the better half of the industry: NOTV outperforms 70.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.89 |
ROIC/WACCN/A
WACC9.29%
2.3 Liquidity
A Current Ratio of 0.31 indicates that NOTV may have some problems paying its short term obligations.
With a Current ratio value of 0.31, NOTV is not doing good in the industry: 98.18% of the companies in the same industry are doing better.
NOTV has a Quick Ratio of 0.31. This is a bad value and indicates that NOTV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NOTV (0.23) is worse than 98.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.23 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.19% over the past year.
NOTV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.95%.
NOTV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 85.16% yearly.
EPS 1Y (TTM)5.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1528.57%
Revenue 1Y (TTM)-13.95%
Revenue growth 3Y111.51%
Revenue growth 5Y85.16%
Sales Q2Q%-32.82%
3.2 Future
NOTV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.18% yearly.
NOTV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.31% yearly.
EPS Next Y-10.07%
EPS Next 2Y16.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.44%
Revenue Next 2Y-4.7%
Revenue Next 3Y5.93%
Revenue Next 5Y8.31%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NOTV is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.82 |
4.3 Compensation for Growth
NOTV's earnings are expected to grow with 16.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NOTV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INOTIV INC
NASDAQ:NOTV (11/21/2024, 4:30:01 PM)
3.41
+0.2 (+6.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap88.69M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.81% | ||
| ROE | -54.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.93% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.23 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-10.07%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.95%
Revenue growth 3Y111.51%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y